Zensar’s acquisition of BridgeView Life Sciences significantly enhances our capabilities in supporting product launches and commercialization for pharmaceutical and medical device companies. This strategic move not only strengthens our service offerings for current clients but also opens doors for innovative and emerging players in the pharma and medtech sectors. BridgeView’s expertise in Veeva implementation, including its status as a Veeva “Preferred Services Partner” and “Services Partner,” further solidifies our position as a leading trusted technology partner. BridgeView also specializes in Veeva Vault Clinical, Quality, and RIM implementation and support. 

With our global reach, we deliver an array of technology enablement services, including SaaS solutions such as SFDC and ERP, experience services, analytics and gen AI, cloud and infrastructure, digital factory, and agency services. Our mission is to engineer digital experiences that can be developed into scalable products and solutions, driving excellent engagement for our clients. This synergy helps us deliver transformational programs that enhance patient outcomes with greater impact.